SLBT is SL Science Holding Limited Ordinary Shares (Healthcare) — a non-dividend-paying stock. Trading at $2.88. Market cap: $1.61B.
Stock snapshot
| Price | $2.88 |
| Market cap | $1.61B |
| Sector | Healthcare |
| Exchange | XNAS |
| Pays dividend | No |
About SLBT
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
Related non-dividend companies
Other non-dividend stocks investors research alongside SLBT. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is SLBT's current stock price?
SLBT (SL Science Holding Limited Ordinary Shares) is currently trading at $2.88.
Does SLBT pay a dividend?
SLBT (SL Science Holding Limited Ordinary Shares) does not currently pay a regular dividend.
Track SLBT in DiviDrip
Add SLBT to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search SLBT and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.